Trial Profile
A trial to study the cardiovascular toxicity of abiraterone acetate in metastatic Castration Resistant Prostate Cancer (mCRPC) patients with cardiovascular comorbidities or CAD (coronary artery disease) risk factors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions
- 08 Aug 2016 New trial record